ReviewInternational journal of molecular sciences2014

Small-molecule inhibitors of the receptor tyrosine kinases: promising tools for targeted cancer therapies.

Mohammad Hojjat-FarsangiPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.